Virion\Serion PARVOVIRUS B19 IgG BC122G

The Virion-Serion PARVOVIRUS B19 IgG BC122G test is a qualitative and quantitative enzyme-linked immunosorbent assay (ELISA) designed to detect IgG antibodies to parvovirus B19 in serum or plasma samples. It utilizes virus-like particles (VLPs) composed of recombinant VP2 to accurately identify past exposure to parvovirus B19.

Benefits/Advantages:

• High sensitivity and specificity: The Virion-Serion PARVOVIRUS B19 IgG BC122G test offers reliable and accurate results, ensuring confidence in the diagnosis of parvovirus B19 infection.

• Quick turnaround time: With a streamlined testing process, results can be obtained promptly, allowing for timely decision-making and patient management.

• Convenient and easy to use: The test is user-friendly, making it simple for healthcare professionals to administer and interpret the results.

• Valuable tool for monitoring: This test allows for monitoring the immune status and response to vaccination against parvovirus B19, particularly important for pregnant women to protect the developing fetus from potential complications.